Medicare open enrollment is officially underway, and beneficiaries are facing several significant changes to their health and prescription drug coverage in 2027. For many, that means higher Part D cost thresholds and new prices for some of Medicare's most widely used medications. The annual Medicare open enrollment period began October 15 and runs through December 7.
It’s at this time that beneficiaries can compare their current coverage with other options, including original Medicare, privately run Medicare Advantage plans and prescription drug plans. Coverage choices made during the period will take effect on January 1. In 2027, the Medicare Part D out-of-pocket threshold is rising to $2,400, the federal government is ending a temporary program intended to stabilize standalone Part D premiums, and negotiated prices for 15 additional high-cost drugs will take effect.
Medicare plans can change their premiums, provider networks and cost-sharing requirements from one year to the next, so sticking with the same policy does not necessarily mean receiving identical coverage. In 2027, some beneficiaries will face higher prescription drug cost thresholds while some Medicare Advantage insurers are fully withdrawing plans from particular areas and scaling back benefits. At the same time, Social Security recipients will receive a 3.6 percent cost-of-living adjustment in 2027, adding an estimated $75 to the average retired worker's monthly benefit.
The rising healthcare costs could fully absorb that increase for many. The first major change affects prescription drug spending. Medicare's annual Part D out-of-pocket threshold will rise from $2,100 in 2026 to $2,400 in 2027, meaning beneficiaries with high prescription costs could have to spend an additional $300 before reaching the program's annual limit.
The standard Part D deductible will increase from $615 to $700. Another change is coming to what some beneficiaries pay in monthly Part D premiums. The Centers for Medicare & Medicaid Services (CMS) is ending the Part D Premium Stabilization Demonstration at the end of the year.
CMS has said Part D insurers now have enough experience operating under the redesigned benefit to support their assumptions when setting bids. Therefore, they will be discontinuing the demonstration and returning to "traditional market conditions" in 2027. Premiums are plan-specific.
Extract — continue reading at the source.
